SCHEMBL988945

SCHEMBL988945

O=C(O)Oc1ccc2c(c1)Oc1cc(O)ccc1C21OC(=O)c2c(Cl)c(Cl)c(Cl)c(Cl)c21

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.54
HPGD P15428 3/20 0.54
BRCA1 P38398 2/20 0.54
HSD17B10 Q99714 2/20 0.54
CYP2C9 P11712 1/20 0.54
ALOX15 P16050 1/20 0.54
ALOX12 P18054 1/20 0.54
SMAD3 P84022 2/20 0.49
MEN1 O00255 4/20 0.47
KMT2A Q03164 4/20 0.47
MAPT P10636 2/20 0.47
HTT P42858 2/20 0.47
USP2 O75604 1/20 0.47
LMNA P02545 1/20 0.47
FTO Q9C0B1 8/20 0.45
RECQL P46063 3/20 0.45
TDP1 Q9NUW8 3/20 0.45
BLM P54132 2/20 0.45
CYP2C19 P33261 1/20 0.45
PRMT1 Q99873 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29361906 0.88 ALDH1A1 (0.63) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL134733 0.88 ALDH1A1 (0.63) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL30887310 0.88 ALDH1A1 (0.63) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL30887311 0.88 ALDH1A1 (0.63) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL5453230 0.87 ALDH1A1 (0.62) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL1819444 0.86 ALDH1A1 (0.49) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL4632262 0.85 MEN1 (0.49) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL2978975 0.84 ALDH1A1 (0.49) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL9474938 0.82 HPGD (0.46) ALDH1A1HPGDBRCA1HSD17B10CYP2C9
SCHEMBL5148271 0.81 ALDH1A1 (0.59) ALDH1A1HPGDBRCA1HSD17B10CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010030049-A1 COMPOSITION FOR DETECTION OF M. TUBERCULOSIS COMPLEX OR MYCOBACTERIA GENUS AND SIMULTANEOUS DETECTION METHOD FOR M. TUBERCULOSIS COMPLEX AND MYCOBACTERIA GENUS WITH MULTIPLEX REAL TIME PCR USING THE SAME LG LIFE SCIENCES, LTD. (KR) 2010-03-18 WO claimed
WO-2010011884-A2 NOVEL NUCLEIC ACID-BASED MOLECULAR PROBES UNIVERSITY OF FLORIDA RESEARCH FOUNDATION, INC. (US) 2010-01-28 WO claimed
WO-2008153893-A2 METHODS AND SPECIES-SPECIFIC PRIMERS FOR DETECTION AND QUANTIFICATION OF STREPTOCOCCUS MUTANS AND STREPTOCOCCUS SANGUINIS IN MIXED BACTERIAL SAMPLES NEW YORK UNIVERSITY SCHOOL OF MEDICINE (US) 2008-12-18 WO claimed
EP-2454386-B1 INFLUENZA DETECTION METHOD AND KIT THEREFOR AGENCY SCIENCE TECH & RES (SG) 2015-09-16 EP disclosed
EP-2496719-A1 RESISTANT INFLUENZA A VIRUS DETECTION METHOD AND KIT THEREFOR Agency For Science, Technology And Research (SG) 2012-09-12 EP disclosed
US-20120190575-A1 INFLUENZA DETECTION METHOD AND KIT THEREFOR TAN TOCK SENG HOSPITAL (SG) 2012-07-26 US disclosed
EP-2464746-A1 AN ASSAY FOR DETERMINING A MOLECULAR RISK ASSESSMENT OF A COMPLEX POLYMICROBIAL SAMPLE SUSPECTED TO CONTAIN AN EHEC Agence nationale de sécurité sanitaire de l'alimentation,de l'environnement et du travail (FR) 2012-06-20 EP disclosed
EP-2459749-A1 METHOD AND/OR PRIMERS FOR THE DETECTION OF MYCOBACTERIUM TUBERCULOSIS Agency For Science, Technology And Research (SG) 2012-06-06 EP disclosed
US-20120135397-A1 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) DETECTION METHOD AND KIT THEREFOR TAN TOCK SENG HOSPITAL (SG) 2012-05-31 US disclosed
EP-2454386-A1 INFLUENZA DETECTION METHOD AND KIT THEREFOR Agency For Science, Technology And Research (SG) 2012-05-23 EP disclosed
EP-2451979-A1 HUMAN IMMUNODEFICIENCY VIRUS TYPE 1 (HIV-1) DETECTION METHOD AND KIT THEREFOR Agency For Science, Technology And Research (A*star) (SG) 2012-05-16 EP disclosed
EP-2132339-A1 METHOD FOR THE DETECTION OF AN ANALYTE IN BIOLOGICAL MATRIX Chimera Biotec GmbH (DE) 2009-12-16 EP disclosed
WO-2009141730-A1 PROCESS FOR DETECTING BOTULINUM NEUROTOXIN PRODUCING ORGANISMS AGENCE FRANCAISE DE SECURITE SANITAIRE DES ALIMENTS (FR) 2009-11-26 WO disclosed
WO-2009089635-A1 TREATING NEURODEGENERATIVE DISEASES WITH PROGRANULIN (PGRN) NEURODYN, INC. (CA) 2009-07-23 WO disclosed
WO-2008153893-A2 METHODS AND SPECIES-SPECIFIC PRIMERS FOR DETECTION AND QUANTIFICATION OF STREPTOCOCCUS MUTANS AND STREPTOCOCCUS SANGUINIS IN MIXED BACTERIAL SAMPLES NEW YORK UNIVERSITY SCHOOL OF MEDICINE (US) 2008-12-18 WO disclosed
WO-2008122310-A1 METHOD FOR THE DETECTION OF AN ANALYTE IN BIOLOGICAL MATRIX CHIMERA BIOTEC GMBH (DE) 2008-10-16 WO disclosed
EP-1954833-A2 DIAGNOSTIC AND THERAPEUTICS FOR CARDIOVASCULAR DISORDERS Interleukin Genetics, Inc. (US) 2008-08-13 EP disclosed
EP-1859061-A1 DETECTION METHOD FOR LJUNGAN VIRUS Apodemus Aktiebolag (SE) 2007-11-28 EP disclosed
WO-2007061906-A2 DIAGNOSTIC AND THERAPEUTICS FOR CARDIOVASCULAR DISORDERS INTERLEUKIN GENETICS, INC. (US) 2007-05-31 WO disclosed
WO-2006097723-A1 DETECTION METHOD FOR LJUNGAN VIRUS APODEMUS AB (SE) 2006-09-21 WO disclosed